Best HRT for Menopause: The Safest Form for Your Situation

What is the best HRT for menopause? The short answer

Hormone replacement therapy, or HRT, replaces some of the estrogen your ovaries stop making. Every FDA-approved form made for hot flashes relieves them well. The Menopause Society's 2022 position statement rates the different formulations, doses and routes as comparably effective for those symptoms.

Still deciding whether to take it at all? Start with do I need HRT.

So the best HRT is not the strongest one. It is the form whose risks fit your body and history, in a routine you will actually keep.

For a healthy woman under 60, or within 10 years of her last period, the common first choice looks like this:

• Estrogen: estradiol, the same estrogen your ovaries made, absorbed through the skin from a patch, gel or spray. Doctors call this route transdermal.
• Protection for the uterus: if you still have one, micronized progesterone. It is a capsule identical to the progesterone your body makes, ground into fine particles so it absorbs well.
• No uterus: estrogen on its own, with no progesterone needed.

Four things can move you away from that default. They are whether you have a uterus, your age and time since menopause, your personal risk of clots and stroke, and which symptoms bother you most.

The Menopause Society says the benefits generally outweigh the risks for women under 60 or within 10 years of menopause who have no reason to avoid hormones. Starting later shifts that balance, as the profile list below shows.

If you are still weighing hormones against other treatments, our overview of menopause treatment options compares them side by side. Here, the question is which version of HRT fits you.

What is the safest form of HRT?

Safety in HRT turns on three choices: the route, the type of estrogen and the type of progestogen. Progestogen is the umbrella word for progesterone and its lab-made cousins, called progestins.

Through the skin is gentler on clotting than a pill

Estrogen swallowed as a pill passes through the liver first. There it pushes up proteins that help blood clot. Estrogen absorbed through the skin largely skips that first pass.

A large case-control study by Vinogradova and colleagues in the BMJ used UK primary care records. It compared more than 80,000 women who had a clot in a vein with matched women who had not.

Oral HRT was linked to higher odds of a vein clot, about 1.6 times those of women not using hormones. Patches, gels and sprays showed no significant increase. The authors called the transdermal route the safest option.

A French case-control study called ESTHER pointed the same way. Oral estrogen was linked to more vein clots, while transdermal estrogen was not.

Both are observational studies, which find links rather than prove cause. No randomized trial has compared pills and patches head to head for clots. The Menopause Society says the data suggest less risk with transdermal estrogen, but trial proof is lacking.

Stroke risk follows the dose

Stroke tells a dose story. In a UK study of more than 15,000 women who had a stroke, low-dose estrogen patches showed no added risk compared with no HRT.

Higher-dose patches were linked to nearly double the risk. This study was observational too. The Menopause Society adds that lower doses of either pills or patches may carry less stroke risk.

Estradiol looks safer than conjugated estrogens

Not every estrogen is the same molecule. Conjugated estrogens, sold as Premarin, are a blend purified from the urine of pregnant mares. Estradiol matches what your ovaries made.

In the Vinogradova study, oral estradiol carried a lower clot risk than conjugated estrogens. The riskiest pairing was conjugated estrogens with medroxyprogesterone acetate. That is the combination tested in the large US Women's Health Initiative trial, known as the WHI.

The progestogen matters too

Micronized progesterone has the more reassuring signals for both breast cancer and clots. The progesterone section below walks through that evidence.

Low-dose vaginal estrogen is its own category

Low-dose vaginal creams, tablets, inserts and rings act mainly where they are placed. The Menopause Society describes minimal absorption into the blood. They are not designed for hot flashes, but for dryness and urinary symptoms they are the lowest-risk hormone option.

In February 2026, the FDA removed the heart, breast cancer and dementia warnings from the boxed warning, its strongest alert, on a first group of six HRT products.

Our guide to HRT benefits and risks gives the risk numbers and the full story of that change.

One thing has not changed. HRT is a symptom treatment, not a heart treatment, and The Menopause Society notes it is not approved to prevent heart disease.

Which HRT fits your situation? Form by profile

Use this as a map for your appointment. Each line names the form most often offered in that situation and the reason behind it.

• If you still have a uterus: estrogen plus a progestogen, or one product that combines them. Estrogen alone thickens the uterus lining, called the endometrium, and raises the risk of endometrial cancer. The progestogen keeps the lining in check.
• If you have had a hysterectomy: estrogen alone, with no progestogen needed. The Menopause Society notes estrogen alone has a more favorable safety profile than the combination, so longer use may be appropriate.
• If your clot risk is higher: low-dose estradiol through the skin. In a 2013 committee opinion, ACOG named obesity, immobilization and fracture as factors that add to the clot risk of estrogen. It asked clinicians to weigh the possible clot-sparing benefit of transdermal forms.
• If you have migraine with aura: estrogen through the skin is the usual choice. Aura is the flashing lights or blind spots that come before some migraines. The 2024 guideline on primary ovarian insufficiency, or POI, co-written by the US group ASRM, advises transdermal estrogen for women with POI who have it.
• If you have had a blood clot, stroke or heart attack: current FDA labels list these as reasons not to use systemic estrogen, meaning estrogen that travels through the whole bloodstream. The Menopause Society counts them among its contraindications too. Non-hormonal treatments are the main alternative for hot flashes.
• If vaginal dryness, painful sex or urinary symptoms are your only problem: low-dose vaginal estrogen on its own. The Menopause Society prefers it over systemic therapy when genital and urinary symptoms are the only reason for treatment.
• If you are in perimenopause, still bleeding and need birth control: HRT doses do not prevent pregnancy. A hormonal IUD can protect the lining and prevent pregnancy, though that use is off-label in the US, meaning not FDA-approved for it. A low-dose combined pill suits some healthy nonsmokers. Our perimenopause birth control guide covers who can use which.
• If your menopause came before 40, or early: HRT until at least the average age of menopause, which The Menopause Society puts at about 52. The 2024 POI guideline also recommends it until the usual age of menopause. POI means the ovaries stop working normally before 40. WHI results in older women do not apply here.
• If you are over 60 or more than 10 years past menopause: more caution, a lower dose and usually a transdermal route. The Menopause Society says starting at this stage needs careful weighing, because the risks of heart disease, stroke, clots and dementia are higher. For older women it lists switching from pills to skin and lowering the dose as ways to reduce risk.
• If you have had breast cancer or another estrogen-sensitive cancer: systemic HRT is generally not advised, and FDA labels list breast cancer as a contraindication. The Menopause Society says low-dose vaginal estrogen may be considered with your oncologist if non-hormonal options fail. For hot flashes, see our comparison of Veozah and HRT.
• If you are allergic to peanuts: Prometrium, the best-known micronized progesterone capsule, contains peanut oil, and its label rules it out for you. A synthetic progestin or a hormonal IUD can protect the lining instead.
• If you want the fewest steps: a patch changed once or twice a week, or a ring changed every three months. Gels and sprays are daily. Bijuva puts estradiol and progesterone in one evening capsule.
• If low sex drive is a main complaint: The Menopause Society says estrogen through the skin may be preferable to pills. Oral estrogen raises a protein that binds testosterone, leaving less of it free to act. Testosterone itself is covered further down.

Patch, gel, spray, pill or ring: what each HRT option is

All of these deliver estrogen. They differ in how often you use them, how the hormone enters your body and what daily life looks like.

Estrogen patches

A patch is a thin sticker worn on the lower belly or buttock. Depending on the brand, you change it once or twice a week. It releases a steady dose through the skin.

Combination patches also exist. They pair estradiol with a synthetic progestin, so one sticker covers both jobs.

The downsides are skin irritation and patches that lift with heat, swimming or sweat. Our deep dive on hormone patches for menopause covers brands, placement and how to keep them on.

Gels and sprays

Estradiol gel is rubbed into the skin once a day. Divigel, for example, goes on the upper thigh. The estradiol spray is misted onto the inner forearm.

Both make it easy to fine-tune the dose. The catch is a daily routine and drying time. The FDA has warned that children and pets can be exposed by touching skin where an estradiol spray was applied.

Pills

Oral estradiol is a small daily tablet, and generics are widely available. Conjugated estrogen tablets are the other main option.

Pills are simple. But they pass through the liver first, which explains their higher clot signal in the studies above.

Bijuva: estradiol and progesterone in one capsule

Bijuva combines estradiol with progesterone identical to your own in a single capsule. It is approved for moderate to severe hot flashes in women with a uterus. Its label calls for one capsule each evening with food.

Bijuva was one of the six products relabeled in February 2026. Its new label carries no boxed warning.

Femring: a vaginal ring that treats the whole body

Femring sits in the vagina but releases enough estradiol to reach the bloodstream. Its label covers moderate to severe hot flashes as well as vaginal symptoms. You replace it every three months.

Because it is systemic, it is not the same as a low-dose vaginal ring such as Estring. A woman with a uterus using Femring still needs a progestogen.

Low-dose vaginal estrogen

Creams, small tablets or inserts and the Estring ring treat the vagina, vulva and bladder locally. They get their own section below.

Which progesterone is best if you still have a uterus?

If you have a uterus and use estrogen that reaches the bloodstream, you need a progestogen. The FDA kept a boxed warning on exactly this point: endometrial cancer from estrogen used alone. There are four main ways to cover it.

Micronized progesterone, the usual first pick

Micronized progesterone is chemically identical to the progesterone your ovaries make. Prometrium is the brand, and generics exist. The Menopause Society lists it among the progestogens commonly given with estrogen.

Prometrium's FDA label covers lining protection in women taking conjugated estrogen tablets. Bijuva, the combination capsule, is approved with estradiol.

The label says to take it at bedtime. Some women feel very drowsy or dizzy after a dose, especially at first. The Menopause Society notes a mild sedating effect and cites a review in which women fell asleep faster.

On breast cancer, the best-known data come from the French E3N cohort study. Estrogen with micronized progesterone showed no rise in breast cancer risk compared with never using HRT. Estrogen with most synthetic progestins was linked to a higher risk.

That finding is observational. The Menopause Society says some but not all studies show this difference, and randomized trials are needed to confirm it.

For clots, the ESTHER study found no link with micronized progesterone, while certain synthetic progestins were linked to higher risk. The Menopause Society says micronized progesterone may be less likely to cause clots than other progestins.

Synthetic progestins

Progestins are lab-made relatives of progesterone. The ones most used with HRT are medroxyprogesterone acetate, norethindrone acetate and levonorgestrel. They come as pills or inside combination patches.

They protect the lining well. Their drawback is a less reassuring signal for breast cancer and clots in the observational studies above. For a woman who cannot take progesterone, they remain a valid choice.

A hormonal IUD

A levonorgestrel IUD, such as Mirena, releases progestin right inside the uterus. The Menopause Society says this off-label use can protect the lining and prevent pregnancy for women starting HRT before their final period. It adds that clinical trial data for this use are limited.

Mirena's US label covers birth control and heavy periods, not lining protection during HRT. Our guide to the Mirena IUD in perimenopause covers the details.

Duavee: estrogen without a progestogen

Duavee pairs conjugated estrogens with bazedoxifene. Bazedoxifene is a SERM, a drug that blocks estrogen in some tissues and mimics it in others. Here it shields the uterus lining, so no progestogen is needed.

Its label limits it to women with a uterus and says not to add other estrogens. It was not in the first group of updated labels, so it still carries the older boxed warning.

How the schedule shapes bleeding

Taking a progestogen for part of each month usually brings a monthly bleed. Taking it every day aims for no bleeding at all, which many women prefer. The Menopause Society says unscheduled bleeding that lasts beyond six months on combined HRT should be investigated.

Bioidentical HRT: FDA-approved vs compounded, and pellets

Bioidentical means a hormone with the same structure as the one your body makes. The word is used as a selling point, but it covers two very different things.

FDA-approved bioidentical hormones already exist. Estradiol patches, gels, sprays and pills qualify, and so does micronized progesterone. The Menopause Society notes these are regulated and monitored for purity and strength, and come with full prescribing information.

Compounded hormones are mixed by a pharmacy for one patient, and they are not FDA-approved. The Menopause Society lists concerns about minimal regulation, overdosing and underdosing, impurities, lack of sterility and missing safety data.

A 2020 report from the National Academies of Sciences, Engineering, and Medicine found insufficient evidence of their clinical usefulness. It advised using them only for an allergy to an ingredient in approved products, or when a needed dosage form does not exist.

Pellets are small compounded implants placed under the skin, often containing estradiol or testosterone. The same report said they should be considered for the FDA's list of drugs that are difficult to compound. Once placed, a pellet cannot simply be peeled off like a patch.

Saliva and urine hormone tests are often sold alongside compounded plans. The Menopause Society calls them unreliable for setting doses and does not recommend them.

For prices and how these programs work, see our pages on compounded HRT and HRT pellets.

When vaginal estrogen alone is the best HRT

Genitourinary syndrome of menopause, or GSM, covers dryness, burning, painful sex, urinary urgency and repeat bladder infections caused by low estrogen. Unlike hot flashes, it tends to worsen over time without treatment.

When those are your only symptoms, The Menopause Society prefers low-dose vaginal estrogen over systemic HRT. It comes as a cream, a small tablet or softgel insert, or a soft ring that lasts three months.

So little reaches the bloodstream that a progestogen is generally not needed, even with a uterus. The Menopause Society adds that trial data on lining safety beyond one year are lacking.

Estring, a low-dose vaginal ring, was among the six products updated in February 2026, and its new label has no boxed warning. The Menopause Society backed removing that warning, calling vaginal estrogen a safe and effective therapy.

The Menopause Society also says low-dose vaginal estrogen can be used at any age and for as long as needed. Our guide to the lowest effective HRT dose shows how vaginal doses compare with systemic ones.

Is there a best HRT for weight loss?

No. HRT is not a weight-loss treatment, and no form is approved for it. A 2026 clinical review in Obesity Pillars says it should not be marketed or prescribed for weight loss. Our guide to HRT and weight loss covers what hormones can and can't do for the scale.

The reassuring part is that HRT does not appear to cause weight gain either. The Menopause Society notes that in the WHI trial, weight gain over three years did not differ significantly between hormones and placebo.

The Menopause Society concludes that HRT may slightly limit belly fat and midlife weight gain, but the effect is small.

Route matters for blood fats. A review of studies published from 1974 to 2000 found that oral estrogen raised triglycerides, a type of blood fat, while transdermal estradiol lowered them. That can matter if your triglycerides already run high.

You may read that HRT preserves muscle. The Menopause Society reports that systematic reviews found neither benefit nor harm to muscle mass.

Our guide to HRT and weight gain in perimenopause goes deeper. If medical weight loss is your goal, see how GLP-1 medicines fit around menopause.

What about testosterone?

Testosterone is not a treatment for hot flashes or general menopause symptoms. The 2019 Global Consensus Position Statement on testosterone for women names only one evidence-based use.

That use is hypoactive sexual desire disorder, or HSDD, in postmenopausal women. HSDD means low desire that causes real distress, diagnosed after a full assessment. The statement found no effect on general wellbeing or depressed mood.

No testosterone product is FDA-approved for women in the US. Prescribers use male products at much lower doses, with blood levels monitored. The consensus advises against compounded testosterone when an approved product can be used.

The FDA is now looking at the question. It held a public workshop on testosterone in menopausal women on September 17, 2026, with public comments open until October 19, 2026.

How you and your clinician land on your best HRT

Most women start at a low dose in the form that fits their profile, then adjust. The Menopause Society notes that lower doses can take 6 to 8 weeks to bring full relief.

So judging a new regimen after a week or two is too early. The Menopause Society lists breast tenderness, bloating, headaches, breakthrough bleeding and progestogen-related mood swings among the more common side effects.

If one form does not suit you, another often can. A patch that irritates your skin can become a gel or spray. A pill can switch to a transdermal form. A progestogen that does not agree with you can be swapped for another type.

The Menopause Society describes this as a shared decision with your prescriber, reviewed regularly rather than given a fixed end date. It sees no reason to stop routinely at 60 or 65.

A few signs call for prompt care on any HRT. FDA labels say to stop estrogen if a clot or stroke occurs, or if vision is suddenly lost. Bleeding after menopause should always be checked.

Our guides to HRT side effects and the lowest effective HRT dose cover the fine-tuning.